Sirtuin Modulators: Targets for Metabolic Diseases and Beyond

E-ISSN： 1873-4294|8|17|1533-1544

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.8, Iss.17, 2008-11, pp. : 1533-1544

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PPARs as Targets for Metabolic and Cardiovascular Diseases

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 8, 2005-08 ,pp. : 741-753

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Modulators of PPAR Activity as New Therapeutic Tools in Metabolic Diseases

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 1, 2006-03 ,pp. : 33-43

Bentham Science Publishers

Access to resources Recommend Favorite

Sirtuin Modulators: Mechanisms and Potential Clinical Implications

Current Medicinal Chemistry, Vol. 19, Iss. 15, 2012-04 ,pp. : 2414-2441

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic issue: Metabolic Diseases: Drugs and Mitochondrial Targets)

Current Medicinal Chemistry, Vol. 22, Iss. 20, 2015-01 ,pp. : 2406-2406

Bentham Science Publishers

Access to resources Recommend Favorite

Mast Cell Chymase and Tryptase as Targets for Cardiovascular and Metabolic Diseases

Current Pharmaceutical Design, Vol. 19, Iss. 6, 2013-02 ,pp. : 1114-1125

Bentham Science Publishers

Access to resources Recommend Favorite